Company
Numab Therapeutics
- Biotech
- Location:
- Horgen, Switzerland
Description
Numab Therapeutics engineers multispecific antibodies, combining antibody engineering and Swiss scientific expertise to build a proprietary next-generation therapeutic pipeline for immunology, inflammation, and oncology programs.
Numab Therapeutics is located in the Zurich ecosystem.
Related
LabGenius TherapeuticsLabGenius Therapeutics builds ML-driven discovery and optimisation for therapeutic antibodies, providing the EVA™ platform to design, test…
BioInvent InternationalBioInvent International discovers and develops antibody therapeutics for cancer treatment, using immunology, cancer biology, antibody…
ThelperThelper develops antiviral antibody–drug conjugates that target a virally encoded biomarker abundantly expressed in aggressive, metastatic…
XENOTHERAXENOTHERA develops glyco humanized antibody technology for immunological treatments, lists pipeline products and clinical trials for…
ScientaLabScientaLab develops a foundation model that predicts human immune response in immunology and inflammation, using multi-disease,…
GratXrayGratXray develops breast cancer imaging technology, including senoa breast CT, combining scientific work with safer, more reliable,…
Laigo BioLaigo Bio develops SureTACs, bispecific molecules that bind membrane targets and membrane E3 ligases to drive ubiquitin-mediated, lysosomal…
NETRIS PharmaNETRIS Pharma develops therapeutics that target Netrin-1 to overcome resistance to oncology treatments, producing monoclonal antibodies…
Rab DiagnosticsRab Diagnostics develops biomarker tools, assays and the RabCANCER platform to predict antibody–drug conjugate response for pharma…